Acquisition by Mark Lappe of 9500 shares of Inhibrx at 15.21 subject to Rule 16b-3

All Stories . Acquisition . 
Mark Lappe .  Story
INBX Stock  USD 15.45  1.13  6.82%   
Slightly above 62% of Inhibrx's investor base is looking to short. The analysis of the overall investor sentiment regarding Inhibrx suggests that many traders are alarmed. Inhibrx's investing sentiment can be driven by a variety of factors including economic data, Inhibrx's earnings reports, geopolitical events, and overall market trends.
  
Filed transaction by Inhibrx Director, Officer: Chief Executive Officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at macroaxis.com
Published over two months ago
View all stories for Inhibrx | Inhibrx Hype Analysis
Acquisition of 9500 common stock at 15.21 of Inhibrx by Mark Lappe on 9th of September 2024. This event was filed by Inhibrx with SEC on 2024-09-09. Statement of changes in beneficial ownership - SEC Form 4